Inside Biotech podcast interviews CEO, Michael Heltzen
heltzenpress clippings
Podcast: 'Inside Biotech' interviews CEO, Michael HeltzenOctober 2, 2025
CCO Damien Perriman and co-founder and VP of Development, Dr. Paul Opgenorth.
press releasescience
Driving the cell-free revolution: eXoZymes leaders join BioMADE Leadership & Technical CommitteesSeptember 30, 2025
MDB Capital: eXoZymes & NCTx: The Breakthrough Opportunity with NCTx and Treating a Global Health Epidemic
heltzeninvestorpress clippingsvideo
MDB Capital: eXoZymes & NCTx: The Breakthrough Opportunity with NCTx and Treating a Global Health EpidemicSeptember 18, 2025
The challenges of SynBio
video
The challenges of SynBioSeptember 15, 2025
Transcript: Q2 2025 Earnings Call
investorvideo
Transcript: Q2 2025 Earnings CallAugust 13, 2025
eXoZymes provides second quarter 2025 update at 5PM EST today
press releaseinvestor
eXoZymes provides second quarter 2025 update at 5PM EST todayAugust 12, 2025
eXoZymes to host second quarter 2025 update on Tuesday August 12, 2025, at 5PM EST
press releaseinvestor
eXoZymes to host second quarter 2025 update on Tuesday August 12, 2025, at 5PM ESTAugust 7, 2025
eXoZymes details biomanufacturing breakthrough: 4 grams of NCT with over 99% purity
press releaseinvestornutraceuticalsvideoscience
eXoZymes details biomanufacturing breakthrough: 4 grams of NCT with over 99% purityJuly 29, 2025
eXoZymes biomanufacturing breakthrough: From concept to gram-scale NCT in only 5 months
press releaseinvestornutraceuticalsvideoscience
eXoZymes biomanufacturing breakthrough: From concept to gram-scale NCT in only 5 monthsJuly 22, 2025
World Bio Markets: AI and Machine Learning - The Silver Bullet we Must Not Dodge
press clippingsvideo
World Bio Markets: AI and Machine Learning - The Silver Bullet we Must Not DodgeJuly 2, 2025
Previous page
Page 4 of 11
Next page